Page last updated: 2024-11-03

procarbazine and Aldrich Syndrome

procarbazine has been researched along with Aldrich Syndrome in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research Excerpts

ExcerptRelevanceReference
"Two patients with the Wiskott-Aldrich syndrome had complete donor lymphoid and hematopoietic engraftment after successful allogeneic bone-marrow transplantation."1.26Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. ( Belli, J; Cassady, R; Geha, R; Levey, R; Nathan, DG; Parkman, R; Rappeport, J; Rosen, FS, 1978)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parkman, R1
Rappeport, J1
Geha, R1
Belli, J1
Cassady, R1
Levey, R1
Nathan, DG1
Rosen, FS1

Other Studies

1 other study available for procarbazine and Aldrich Syndrome

ArticleYear
Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
    The New England journal of medicine, 1978, Apr-27, Volume: 298, Issue:17

    Topics: Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cytara

1978